1.0
25 Mar 2021
Current employee, more than 3 years
Philadelphia, PA
Recommend
CEO approval
Business outlook
Pros
Ken Fraizer, but he is leaving,
Cons
People are vicious, ruthlessly competitive and power hungry. Bullying is accepted. Zero work life-balance in oncology. Painfully hierarchal. Process driven to the point where it stunts growth. Med-legal review process (Regulatory and Legal) is culturally toxic.